Online Program Home
  My Program

All Times EDT

Abstract Details

Activity Number: 287 - Current and Future Challenges in Analyzing Composite Endpoints
Type: Invited
Date/Time: Wednesday, August 5, 2020 : 10:00 AM to 11:50 AM
Sponsor: Lifetime Data Science Section
Abstract #309426
Title: Benefit-Risk Assessment Using a Primary Endpoint and Secondary Measurements
Author(s): Mei-Cheng Wang*
Companies: Johns Hopkins University
Keywords: Benefit-risk assessment; Biomarkers; Composite endpoint; Treatment effects

Benefit-risk assessment is a crucial step in the medical decision process. In many biomedical studies and clinical trials, a failure event is typically considered as the primary endpoint while other longitudinal markers also possess important implications for the evaluation of treatment effect. Thus, questions arise on how to evaluate treatment effects based on the two types of measurements for the purpose of deciding on which treatment is most likely to benefit the patients. In this talk, we present a unified framework for benefit-risk assessment using the observed longitudinal markers and time to he primary endpoint. We propose a composite marker process to synthesize information from these two measurements. We consider nonparametric and semiparametric approaches under two scenarios: (i) the longitudinal marker is measured intermittently during the study period, and (ii) the values of the longitudinal marker are observed throughout the entire follow-up period. A real data example of prostate cancer is used to illustrate the application of the proposed methods.

Authors who are presenting talks have a * after their name.

Back to the full JSM 2020 program